急性性不全性脳卒中の患者における一般的な動脈内側介質の厚さの評価:症例対照研究
Koshy T Sam1, Jayashankar Ca1, Venkataramana Kandi2
1Internal Medicine, Vydehi Institute of Medical Sciences and Research Centre, Bengaluru, IND.
Cureus
|February 12, 2026
まとめ
常発性大動脈内側介質の厚さ (CIMT) は,急性性缺血性脳卒中 (AIS) 患者において,健康な個人に比べて有意に高くなります. この発見は,脳血管疾患のリスクが高い個人を特定するための非侵襲的なツールとしてCIMTをサポートしています.
科学分野:
- 神経学 神経学とは
- 心臓病学 心臓病学
- 血管医学 血管医学とは
背景:
- 脳卒中は世界的に死亡と障害の主な原因であり,インドでは発生率が増加しています.
- 常見の頸動脈内側介質の厚さ (CIMT) は動脈硬化症のマーカーですが,インドの脳卒中リスクとの関連性についてはさらなる研究が必要です.
研究 の 目的:
- インドの急性性性血性脳卒中 (AIS) 患者のCIMTと健康な対照群を評価し,比較する.
- CIMTとAISとの関係を確立する.
- 脳血管疾患に対するCIMTの診断有用性を評価する.
主な方法:
- 展望的,観察的,横断的,症例対照試験をインド・ベンガルールで行いました (2023年3月〜2025年3月).
- 25人のAIS患者 (症例) と25人の健康な個人 (対照群) を含む.
- 頸動脈ドップラーでCIMTを測定し,血液学的および生化学的パラメータを分析した.
主要な成果:
- AISの患者は,対照群 (0.91 ± 0.19 mm) と比較して,CIMTの平均値 (1.11 ± 0.22 mm) を著しく高めた.
- 集団間の全白血球数 (TLC) とヘモグロビン (Hb) レベルにおける有意な差異が観察されました.
- 低密度リポタンパク質は,CIMT.との境界的な有意性 (p=0.05) を示した.
結論:
- CIMTの上昇は,AIS患者の重要な発見です.
- CIMTは,脳血管発作のリスクのある個人を特定するための非侵襲的で費用対効果の高い診断ツールとして機能します.
キーワード:
急性不血性脳卒中 (Acute Ischemic Stroke) とは,急性不血性脳卒中 (Acute Ischemic Stroke) とは,急性の不血性脳卒中 (Acute Ischemic Stroke) とは,急性の不血性脳卒中 (Acute Ischemic Stroke) とは,急性の不血性脳卒中 (Acute Ischemic Stroke) とは,急性の不血性脳卒中 (Acute Ischemic Stroke) とは,急性の不血性脳卒中 (Acute Ischemic Stroke) とは,脳血管系の脳血管系です.常軌動脈 常軌動脈 インティマ・メディア 厚さ非侵襲的ではない.筋トレ 筋トレ 筋トレ 筋トレ 筋トレ 筋トレ関連する概念動画
Common Ion Effect
47.1K
Compared with pure water, the solubility of an ionic compound is less in aqueous solutions containing a common ion (one also produced by dissolution of the ionic compound). This is an example of a phenomenon known as the common ion effect, which is a consequence of the law of mass action that may be explained using Le Châtelier’s principle. Consider the dissolution of silver iodide:
47.1K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
475
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
475
Acute Pyelonephritis II: Diagnostic Studies and Management
445
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
445
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
458
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
458
Acute Coronary Syndrome III: Diagnostic Studies
288
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
288
Bioavailability Study Design: Healthy Subjects Versus Patients
164
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
164


